The global Phage Therapy market size is predicted to grow from US$ 50 million in 2025 to US$ 137 million in 2031; it is expected to grow at a CAGR of 18.3% from 2025 to 2031.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
The 鈥淧hage Therapy Industry Forecast鈥� looks at past sales and reviews total world Phage Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Phage Therapy sales for 2025 through 2031. With Phage Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phage Therapy industry.
This Insight Report provides a comprehensive analysis of the global Phage Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Phage Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Phage Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phage Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phage Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Phage Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Segmentation by Application:
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Phage Therapy 麻豆原创 Size (2020-2031)
2.1.2 Phage Therapy 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Phage Therapy by Country/Region (2020, 2024 & 2031)
2.2 Phage Therapy Segment by Type
2.2.1 DsDNA Bacteriophage
2.2.2 SsDNA Bacteriophage
2.2.3 SsRNA Bacteriophage
2.2.4 Others
2.3 Phage Therapy 麻豆原创 Size by Type
2.3.1 Phage Therapy 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Phage Therapy 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Phage Therapy Segment by Application
2.4.1 Animal Health
2.4.2 Aquaculture
2.4.3 Agriculture
2.4.4 Food Industry
2.4.5 Human Health
2.4.6 Others
2.5 Phage Therapy 麻豆原创 Size by Application
2.5.1 Phage Therapy 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Phage Therapy 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Phage Therapy 麻豆原创 Size by Player
3.1 Phage Therapy 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Phage Therapy Revenue by Player (2020-2025)
3.1.2 Global Phage Therapy Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Phage Therapy Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Phage Therapy by Region
4.1 Phage Therapy 麻豆原创 Size by Region (2020-2025)
4.2 Global Phage Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Phage Therapy 麻豆原创 Size Growth (2020-2025)
4.4 APAC Phage Therapy 麻豆原创 Size Growth (2020-2025)
4.5 Europe Phage Therapy 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Phage Therapy 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Phage Therapy 麻豆原创 Size by Country (2020-2025)
5.2 Americas Phage Therapy 麻豆原创 Size by Type (2020-2025)
5.3 Americas Phage Therapy 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Phage Therapy 麻豆原创 Size by Region (2020-2025)
6.2 APAC Phage Therapy 麻豆原创 Size by Type (2020-2025)
6.3 APAC Phage Therapy 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Phage Therapy 麻豆原创 Size by Country (2020-2025)
7.2 Europe Phage Therapy 麻豆原创 Size by Type (2020-2025)
7.3 Europe Phage Therapy 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Phage Therapy by Region (2020-2025)
8.2 Middle East & Africa Phage Therapy 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Phage Therapy 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Phage Therapy 麻豆原创 Forecast
10.1 Global Phage Therapy Forecast by Region (2026-2031)
10.1.1 Global Phage Therapy Forecast by Region (2026-2031)
10.1.2 Americas Phage Therapy Forecast
10.1.3 APAC Phage Therapy Forecast
10.1.4 Europe Phage Therapy Forecast
10.1.5 Middle East & Africa Phage Therapy Forecast
10.2 Americas Phage Therapy Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Phage Therapy Forecast
10.2.2 Canada 麻豆原创 Phage Therapy Forecast
10.2.3 Mexico 麻豆原创 Phage Therapy Forecast
10.2.4 Brazil 麻豆原创 Phage Therapy Forecast
10.3 APAC Phage Therapy Forecast by Region (2026-2031)
10.3.1 China Phage Therapy 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Phage Therapy Forecast
10.3.3 Korea 麻豆原创 Phage Therapy Forecast
10.3.4 Southeast Asia 麻豆原创 Phage Therapy Forecast
10.3.5 India 麻豆原创 Phage Therapy Forecast
10.3.6 Australia 麻豆原创 Phage Therapy Forecast
10.4 Europe Phage Therapy Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Phage Therapy Forecast
10.4.2 France 麻豆原创 Phage Therapy Forecast
10.4.3 UK 麻豆原创 Phage Therapy Forecast
10.4.4 Italy 麻豆原创 Phage Therapy Forecast
10.4.5 Russia 麻豆原创 Phage Therapy Forecast
10.5 Middle East & Africa Phage Therapy Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Phage Therapy Forecast
10.5.2 South Africa 麻豆原创 Phage Therapy Forecast
10.5.3 Israel 麻豆原创 Phage Therapy Forecast
10.5.4 Turkey 麻豆原创 Phage Therapy Forecast
10.6 Global Phage Therapy Forecast by Type (2026-2031)
10.7 Global Phage Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Phage Therapy Forecast
11 Key Players Analysis
11.1 NPO Microgen
11.1.1 NPO Microgen Company Information
11.1.2 NPO Microgen Phage Therapy Product Offered
11.1.3 NPO Microgen Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 NPO Microgen Main Business Overview
11.1.5 NPO Microgen Latest Developments
11.2 Proteon Pharmaceuticals
11.2.1 Proteon Pharmaceuticals Company Information
11.2.2 Proteon Pharmaceuticals Phage Therapy Product Offered
11.2.3 Proteon Pharmaceuticals Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Proteon Pharmaceuticals Main Business Overview
11.2.5 Proteon Pharmaceuticals Latest Developments
11.3 Phagelux
11.3.1 Phagelux Company Information
11.3.2 Phagelux Phage Therapy Product Offered
11.3.3 Phagelux Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Phagelux Main Business Overview
11.3.5 Phagelux Latest Developments
11.4 Intralytix
11.4.1 Intralytix Company Information
11.4.2 Intralytix Phage Therapy Product Offered
11.4.3 Intralytix Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Intralytix Main Business Overview
11.4.5 Intralytix Latest Developments
11.5 Micreos
11.5.1 Micreos Company Information
11.5.2 Micreos Phage Therapy Product Offered
11.5.3 Micreos Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Micreos Main Business Overview
11.5.5 Micreos Latest Developments
11.6 Eliava BioPreparations
11.6.1 Eliava BioPreparations Company Information
11.6.2 Eliava BioPreparations Phage Therapy Product Offered
11.6.3 Eliava BioPreparations Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Eliava BioPreparations Main Business Overview
11.6.5 Eliava BioPreparations Latest Developments
11.7 Locus Biosciences,Inc
11.7.1 Locus Biosciences,Inc Company Information
11.7.2 Locus Biosciences,Inc Phage Therapy Product Offered
11.7.3 Locus Biosciences,Inc Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Locus Biosciences,Inc Main Business Overview
11.7.5 Locus Biosciences,Inc Latest Developments
11.8 Pharmex Group,LLC
11.8.1 Pharmex Group,LLC Company Information
11.8.2 Pharmex Group,LLC Phage Therapy Product Offered
11.8.3 Pharmex Group,LLC Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Pharmex Group,LLC Main Business Overview
11.8.5 Pharmex Group,LLC Latest Developments
11.9 Pherecydes Pharma
11.9.1 Pherecydes Pharma Company Information
11.9.2 Pherecydes Pharma Phage Therapy Product Offered
11.9.3 Pherecydes Pharma Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Pherecydes Pharma Main Business Overview
11.9.5 Pherecydes Pharma Latest Developments
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Information
11.10.2 APS Biocontrol Ltd. (APS) Phage Therapy Product Offered
11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 APS Biocontrol Ltd. (APS) Main Business Overview
11.10.5 APS Biocontrol Ltd. (APS) Latest Developments
11.11 Qingdao Phagepharm Bio-tech
11.11.1 Qingdao Phagepharm Bio-tech Company Information
11.11.2 Qingdao Phagepharm Bio-tech Phage Therapy Product Offered
11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Qingdao Phagepharm Bio-tech Main Business Overview
11.11.5 Qingdao Phagepharm Bio-tech Latest Developments
11.12 Fixed-Phage Limited
11.12.1 Fixed-Phage Limited Company Information
11.12.2 Fixed-Phage Limited Phage Therapy Product Offered
11.12.3 Fixed-Phage Limited Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Fixed-Phage Limited Main Business Overview
11.12.5 Fixed-Phage Limited Latest Developments
11.13 Zeptometrix
11.13.1 Zeptometrix Company Information
11.13.2 Zeptometrix Phage Therapy Product Offered
11.13.3 Zeptometrix Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Zeptometrix Main Business Overview
11.13.5 Zeptometrix Latest Developments
11.14 Phage International, Inc.
11.14.1 Phage International, Inc. Company Information
11.14.2 Phage International, Inc. Phage Therapy Product Offered
11.14.3 Phage International, Inc. Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Phage International, Inc. Main Business Overview
11.14.5 Phage International, Inc. Latest Developments
11.15 MicroMir
11.15.1 MicroMir Company Information
11.15.2 MicroMir Phage Therapy Product Offered
11.15.3 MicroMir Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 MicroMir Main Business Overview
11.15.5 MicroMir Latest Developments
11.16 iNtODEWORLD, Inc.
11.16.1 iNtODEWORLD, Inc. Company Information
11.16.2 iNtODEWORLD, Inc. Phage Therapy Product Offered
11.16.3 iNtODEWORLD, Inc. Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 iNtODEWORLD, Inc. Main Business Overview
11.16.5 iNtODEWORLD, Inc. Latest Developments
11.17 NEXTBIOTICS
11.17.1 NEXTBIOTICS Company Information
11.17.2 NEXTBIOTICS Phage Therapy Product Offered
11.17.3 NEXTBIOTICS Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 NEXTBIOTICS Main Business Overview
11.17.5 NEXTBIOTICS Latest Developments
11.18 Armata Pharmaceuticals, Inc.
11.18.1 Armata Pharmaceuticals, Inc. Company Information
11.18.2 Armata Pharmaceuticals, Inc. Phage Therapy Product Offered
11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 Armata Pharmaceuticals, Inc. Main Business Overview
11.18.5 Armata Pharmaceuticals, Inc. Latest Developments
11.19 Innophage
11.19.1 Innophage Company Information
11.19.2 Innophage Phage Therapy Product Offered
11.19.3 Innophage Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.19.4 Innophage Main Business Overview
11.19.5 Innophage Latest Developments
11.20 Adaptive Phage Therapeutics
11.20.1 Adaptive Phage Therapeutics Company Information
11.20.2 Adaptive Phage Therapeutics Phage Therapy Product Offered
11.20.3 Adaptive Phage Therapeutics Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.20.4 Adaptive Phage Therapeutics Main Business Overview
11.20.5 Adaptive Phage Therapeutics Latest Developments
11.21 TechnoPhage
11.21.1 TechnoPhage Company Information
11.21.2 TechnoPhage Phage Therapy Product Offered
11.21.3 TechnoPhage Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.21.4 TechnoPhage Main Business Overview
11.21.5 TechnoPhage Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
